Infections and urolithiasis: Current clinical evidence in prophylaxis and antibiotic therapy

Archivio Italiano di Urologia e Andrologia

Volumn 80, Issue 1, 2008, Pages 5-12

  Zanetti, Giampaolo ^a   Paparella, Stefano ^a,b   Trinchieri, Alberto ^b   Prezioso, Domenico ^c   Rocco, Francesco ^a   Naber, Kurt G ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b A MANZONI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibiotic prophylaxis; Antibiotic therapy; Infection; Urolithiasis

Indexed keywords

AMINOPENICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; EXTRACORPOREAL LITHOTRIPSY; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; PATHOGENESIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROPHYLAXIS; RISK FACTOR; SEPSIS; URINALYSIS; URINARY TRACT INFECTION; UROLITHIASIS;

ANTI-BACTERIAL AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY CALCULI; NEPHROSTOMY, PERCUTANEOUS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; RISK FACTORS; SEPSIS; TREATMENT OUTCOME; URETEROSCOPY; URINARY TRACT INFECTIONS;

EID: 42249089067     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Mariappan P, Tolley DA Endoscopic stone surgery: minimizing the risk of post-operative sepsis Curr Opin Urol 2005; 15:101-105.
2. O'Keefe NK, Mortimer AJ, Sambrook PA, Rao PN Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones Br J Urol 1993; 72:277-283.
3. Stamey TA, Pathogenesis and treatment of urinary tract infections (chapter 8). Baltimore: Williams & Wilkins Co. 1980, p.430.
4. Hugosson], Grenabo L, Hedelin H et al.Bacteriology of upper urinary tract stones J Urol 1990; 143: 965-968.
5. Mariappan P, Smith G, Bariol SV, et al. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following PCNL J Urol 2005; 173:1610-1614.
6. Kajender EO, Cifticioglu N Nanobacteria: an alternative mechanism for pathogenic intra and extracellular calcification and stone formation Proc Natl Acad Sci USA 1998; 95:8274-8279.
7. McAleer I, Kaplan GW, Bradley JS et al. Endotoxin content in the renal calculi J Urol 2003; 169:1813-1814.
8. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis clinical guidelines panel summary report on the management of staghorn calculi J Urol 1994; 151:1648-1651.
9. Agashi K, Tanda H, Kato S Characteristics of patients with staghorn calculi in our experience Int J Urol 2004; 11:276-281.
10. Gault MH, Longerich LL, Crane G Bacteriology of urinary tract stones J Urol 1995; 153:1164-1170.
11. Mariappan P, Loong CW Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteric stone or infected stones: a prospective clinical study J Urol 2004; 171:2142-2145.
12. Martinez-Pineiro JA, de Iriarte EG, Armero AH The problem of recurrences and infection after surgical removal of staghorn calculi Eur Urol 1982; 8:94-101.
13. Beck EM, Riehle RA Jr The fate of residual fragments after ESWL monotherapy of infection stones J Urol 1991; 145:6-9.
14. Meretyk S, Gofrit ON, Gafni O Complete staghorn calculi: random prospective comparison between ESWL monotherapy and combined with percutaneous nephrostolithotomy J Urol 1997; 157:780-786.
15. Griffith DP, Gleeson MJ, Lee H, et al. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi Eur Urol 1991; 20:243-247.
16. Silay MS, Miroglu C The risk of urolithiasis recurrence may be reduced with anti-nanobacterial therapy Med Hypotheses 2007; 68/6:1348-1350.
17. Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P; PEP and PEAP-study investigators; Board of the European Society of Infections in Urology: Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 2006; 28 (Suppl 1):S91-107.
18. Malaga B, Hodges SJ, Shah O Percutaneous nephrostolithotomy: impact on access point number and location on complications AUA Annual Meeting 2004 (abstract 1899); May 2004; San Francisco, CA.
19. Cadeddu JA, Chen R, Bishoff J, et al. Clinical significance of fever after percutaneous nephrostolithotomy Urology 1998; 52:48-50.
20. Charton M, Vallancien G, Veillon B, Brisset JM Urinary tract infection in percutaneous surgery for renal calculi J Urol 1986, 135:15-17.
21. Inglis JA, Tolley DA Antibiotic prophylaxis at the time of percutaneous stone surgery J Endourol 1988; 2:59-62.
22. Margel D, Ehrlich Y, Brown N, Lask D, Livne PM Clinical implication of routine stone culture in percutaneous nephrolithotomy- a prospective study Urology 2006; 67:26-29.
23. Mariappan P, Smith G, Moussa SA, Tolley DA One week of Ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study BJU Intern 2006; 98, 1075-1079.
24. Dogan HS, Sahin A, Cetinkaya Y, et al. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients J Endourol 2002; 16:649-653.
25. Auge BK, Pietrow PK, Lallas CD, et al. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation J Endourol 2004; 18:33-36.
26. Naber K Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents, 2001; 17:331-334.
27. Knopf HJ, Graff HJ, Schulze H Perioperative antibiotic prophylaxis in ureteroscopic stone removal Eur Urol 2003; 44:115-118.
28. Tenke P, Kovacs B, Benko R, et al. Continuous versus intermittent levofloxacin treatment in complicated urinary tract infections caused by urinary obstruction temporarily relieved by foreign body insertion Int J Antimicrob 2006; Ag 28S:S82-S85.
29. Costantino G, Condorelli S, Costanzo V, et al. The antibacterial chemoprophylaxis in ureteroscopy: the employment of the levofloxacin used as switch-therapy versus oral treatment with a single 500mg once a day Gazz Med Ital-Arch Sci Med 2005; 164:43-46.
30. Skolarikos A, Alivizatos G, de la Rosette J ESWL 25 years later: complications and their preventions Eur Urol 2006; 50:981-990.
31. Moody FG, Lithotripsy in the treatment of renal stones. Am J Surg. 1993; 165:479-82.
32. Dincel et al. Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types J Endourol 1998.
33. Bierkens AF, Hendrikx AJ, Ezz el Din KE, de la Rosette JJ, et al. The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment Eur Urol. 1997; 31:30-5.
34. Pettersson B Are prophylactic antibiotics necessary during extracorporeal shockwave lithotripsy?, Br J Urol 1989; 63:449-452.
35. Zanetti G, Montanari E, Trinchieri A, SWL and urinary infection in pretreatment non infected patients in Urology 1992, Monduzzi Editore, Bologna 1992; p. 7.
36. Naber KG, Bishop MC, Bjerklund-Johansen TE, Botto H, Cek M, Grabe M, Label B, Palou J, Tenke P: Guidelines on the management of urinary and male genital tract infections. Peri-operative antibacterial prophylaxis in urology. In European Association of Urology Guidelines 2006 Edition, Drukkerij Gelderland, Arnhem (the Netherlands) 2005, pp. 100-9.
37. Musk DJ Jr, Hergenrother PJ. Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr Med Chem. 2006; 13:2163-77.
38. Goto T, Nakame Y, Nishida M, Ohi Y.Bacterial biofilms and catheters in experimental urinary tract infection. Int J Antimicrob Agents. 1999; 11:227-31.
39. Goto T, Nakame Y, Nishida M, Ohi Y. In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology. 1999; 53:1058-62.
40. Mihuniya T, Kato Y, Kariyama R, Monden K, Hikida M, Kumon H.Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta Med Okayama. 2005; 59:209-16.